Search Results

Researchers Share Key Career Advice with LLS College Club Members

I recently had the privilege of moderating an LLS on Campus Researcher Panel attended by LLS college club members from nearly 30 universities across the country. These clubs bring together students interested in pursuing health-related careers and provide opportunities to hear from scientists working to better understand and treat blood cancers.  

Surviving ALL: An Intimate Look at How Cancer Affected the Careers, Relationships & Fertility of Four Young Adults

A cancer diagnosis is a devastating blow for people of all ages, but presents special challenges for young adults. This period of life is usually a time of transition as they are embarking on journeys such as school, relationships and careers. A cancer diagnosis can bring their lives to a screeching halt in the midst of these new adventures.

Meet the Researcher: Omar Abdel-Wahab, MD

This is part of a periodic series of Q&A’s with LLS-funded researchers. Dr. Abdel-Wahab of Memorial Sloan Kettering Cancer Center focuses on an area of research called epigenetics – chemical modifications that regulate (switch on and off) gene activity. He is studying how these processes drive the development of acute myeloid leukemia and other blood cancers. He currently holds a Career Development Program grant from LLS, a program that supports scientists earlier in their careers.

Q. What is the focus of your research and its primary goal?

Champions in myeloma research: A conversation with Urvi A. Shah, M.D. M.S.

March is Myeloma Awareness Month, and it’s also Women’s History Month. So what better time to spotlight LLS-funded women scientists who are driving discovery for myeloma patients.

In this first of my two-part series on myeloma researchers, I sat down with Urvi A. Shah, MD, MS, an Assistant Attending in the Myeloma Service at Memorial Sloan Kettering Cancer Center. 

Meet the Researcher: Charlene Liao, PhD

Our “Meet the Researcher” series on The LLS Blog shares what our outstanding LLS-funded researchers are working on, the incredible impact they’re making in the fight against blood cancers, and what inspires their efforts to find better treatments and cures.

Career Development Program FAQ

Career Development Program (CDP)

Apply to the Career Development Program (CDP)

Creating Great Investigators: LLS’s New Pathway To Medical Science For Underrepresented Minorities

Meet the Researcher: Maria Figueroa, MD

Our “Meet the Researcher” series on The LLS Blog shares what our outstanding LLS-funded researchers are working on, the incredible impact they’re making in the fight against blood cancer, and what inspires their efforts to find better treatments and cures. Dr. Maria “Ken” Figueroa, Associate Professor and Co-Leader of the Cancer Epigenetics Research Program at Sylvester Comprehensive Cancer Center, part of the University of Miami Health System, is focused on an exciting area of research called epigenetics.

Meet Three Women in Science Championing Myeloma Cures and Care

Helping Survivors Lead Longer Better Lives

Late last year I had the privilege of attending a special screening of the documentary American Symphony. The film chronicles the experiences of writer Suleika Jaouad and her husband musician Jon Batiste after learning that her acute myeloid leukemia (AML) had returned after years of remission. The movie shows how the couple navigates uncertainty, treatment, and their new normal afterwards. 

Champions in myeloma research, Part 2: A conversation with Suzanne Lentzsch, M.D., Ph.D.

To commemorate both Myeloma Awareness Month and Women’s History Month during March, I’ve been talking with LLS-funded women scientists who are driving discovery for myeloma patients. As we close out the month and my two-part series on myeloma researchers, I’m excited to share my recent conversation with Suzanne Lentzsch, M.D., Ph.D., Professor of Medicine and the Director of the Multiple Myeloma and Amyloidosis Program at Columbia University. 

Meet The Researcher: Dr. Christopher R. Flowers

Meet The Researcher: Dr. Rayne Rouce

First Day Message from LLS's New President and CEO

Honoring Blood Cancer Survivors

Throughout June, in commemoration of #NationalCancerSurvivorMonth, we at LLS have been highlighting the resilience and achievements of blood cancer survivors. I’ve treated so many incredible young survivors in my years as a pediatric hematologist oncologist, and all of them hold a special place in my heart. 

A Farewell Message from LLS's Past President & CEO Louis J. DeGennaro, Ph.D.

Dear Friends, 

Nutrition Advice from a Dietitian & Blood Cancer Survivor

76-year-old Barbara Borrell is a woman who wears many hats – a 50+ year registered dietitian, nutrition consultant and educator, cancer advocate, volunteer with The Leukemia & Lymphoma Society, and a blood cancer survivor who has battled not one, not two, but three types of blood cancer.

Bold goal, bold action

As we observe World Cancer Day, I’m reflecting on my own family’s experience with blood cancer, the children with blood cancer I have had the honor of knowing, and the many individuals and families who have been impacted by a blood cancer diagnosis.

Our work at The Leukemia & Lymphoma Society (LLS) has had a positive impact on so many, but we can do even more to accelerate progress for the blood cancer patients we serve.

Beyond the diagnosis: How employers can champion employees facing cancer

“When someone faces cancer, they shouldn't have to go it alone.” – Orlando Ashworth, CPO, LLS

Cancer doesn’t just impact an individual. It sends ripples through families, friendships, and workplaces. 

Work, School & Finances

Some people continue to work or attend school through cancer treatment, but others are not able to do so. Talk to your healthcare team to know what to expect from treatment so you can make the decision that is best for you.

One More 'Ologist'

After staring down Stage IV non-Hodgkin lymphoma in 2016, I AM HERE, and I am grateful beyond measure. However, I am learning that the treatments that saved my life came at a high cost, and that in its own way survivorship is the hardest part of what I and my family now call, “the adventure.” 'The adventure' is certainly never what we imagined it would be.

Bishoy

Born in Egypt, at the age of three, me and my family immigrated to the U.S. when I was diagnosed with acute lymphoblastic leukemia (ALL). I grew up in Long Island, New York, where I received treatment for 10 years. On my 13th birthday, I underwent brain surgery and remains cancer-free.